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INBRED (syngeneic) animals readily accept transplants of normal tissues
without the evocation of an immunological response. Transplants of tumour
tissue will also grow in syngeneic hosts although, by suitable immunological
procedures, it has been shown that many experimentally-induced tumours possess
transplantation-type antigens which are foreign to their hosts and can elicit a
weak immunological response in syngeneic hosts, or even in the autochthonous
host.
Many carcinogenic agents (chemicals, radiations and viruses) are known to
depress some immunological functions. Although correlation between the degree
of immune depression and carcinogenic potency is imperfect (Berenbaum, 1964),
there have been suggestions that the process of carcinogenesis may necessarily
involve interference with the immunological response of the host (Rubin, 1960;
Prehn, 1963; Burnet, 1964). It might be expected, then, that animals which are
suffering from some long-acting impairment of immunological functions would be
more susceptible to the action ofvarious carcinogenic agents. The work ofMiller
(1961) showed that neonatal thymectomy of mice resulted in permanent immuno-
logical impairment and there have since been several reports of the increased
susceptibility of neonatally-thymectomised mice to the carcinogenic effect of
various polycyclic hydrocarbons and certain oncogenic viruses (Vandeputte et al.,
1963; Miller et al., 1963; Malmgren et al., 1964; Kirchstein et al., 1964; Grant and
Miller, 1965; Nishizuka et al., 1965; Johnson, 1968).
Miller's work (1961), which indicated the importance of the thymus in the
development of normal immunological function, led Maisin to embark on a series
of experiments in which mice undergoing carcinogen treatment received regular
implants of thymus tissue from very young animals. He obtained a significant
delay in skin tumour appearance in mice painted three times per week with methyl-
cholanthrene (MC) and grafted twice a month with isologous thymus glands from
6- to 10-day-old animals (Maisin, 1963) and even better protection withhomogenate
of 2- to 5-day-old thymus glands injected intraperitoneally (Maisin, 1964). He
considered that the protective effect might be due to some kind of hormonal
influence of the thymus tissue helping to restore the immune response depressed
by the carcinogen, thereby aiding the host in recognising the abnormal anti-
genicity of developing tumour cells and promoting their destruction.
The original aim ofthe present experiments was to see whether regular thymus
grafting would delay the MC-induction of sarcomas in mice and to study the
antigenic properties of the tumours so induced. A pilot experiment was set up
with this intention but, after a while, it became clear that with available animal
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resources it would be impossible to increase the experimental numbers. Never-
theless, the results of this pilot study are reported here in view of some interesting
findings concerning the influence of sex on sarcoma induction by MC.
MATERIALS AND METHODS
Mice
The animals used were F1 generation hybrids derived from C57BL/Bcr mothers
and IF/Bcr fathers. Both parental strains are free from mammary tumour agent,
but IF females and the F1 hybrids are known to be highly susceptible to mammary
carcinogenesis following fortnightly skin paintings of MC in olive oil (Marchant,
1967). Equal numbers of both sexes were used, as had been done in Maisin's
experiments. They were housed in metal cages, six animals of the same sex per
box, and were fed on Diet 42 (Thompson's) with water ad libitum.
Thymnus grafting
Half of the animals of each sex received a subcutaneous graft of one whole
thymus gland (both lobes) once a fortnight from the age of 2 months. Each graft
was removed aseptically from a syngeneic animal of the same sex aged from 6 to
10 days old. Grafting was continued throughout the latent period of tumour
induction, grafts being introduced by a trochar on each flank alternately.
Carcinogen treatment
Five weeks after the first thymus graft the experimental animals, with a
similar number of control animals, received a subcutaneous injection on the right
flank of 0.1 ml of 1 per cent (1.0 mg.) 3-methylcholanthrene (MC) in olive oil.
Animals were palpated twice a week and the growth of tumours recorded after
comparison with a graded series of ball-bearings sewn between chamois leather.
Castration
When the results ofthe thymus grafting experiment indicated a sex difference,
ainother experiment was set up. Male and female F1 (C57BL x IF) mice were
castrated at 2 months ofage. Five weeks later they received an injection of 1 mg.
of MC. No thymus grafts were given to these mice.
All mice were examined twice a week for the development of tumours. They
were killed when their sarcomas reached a size of 2 to 3 inch. Many of the
sarcomas were used for antigenicity tests, which are the subject of the following
communication (Marchant, 1969). Histological examination was made of these
and other tumours.
RESULTS
In a number of animals a localised swelling occurred near the injection site
prior to the appearance of a tumour. Sometimes the swelling was diffuse; at
other times it appeared to involve the local inguinal lymph node. Occasionally
the contralateral inguinal node was also enlarged. In some cases the swelling
abated, while in other animals it persisted for several weeks before further definite
tumour growth occurred. For this reason the latent period of tumour induction
was recorded as the latest time at which growth at the injection site was 4 inch
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diameter. The number of mice in each group showing local reactions and the
rate of development of sarcomas is shown in Table I.
TABLE I.-Rate of Development of Sarcomas in Thymus Grafted or Castrated F1
(C57BL x IF) Mice Following Injection of 1 mg. 3-methycholanthrene
Mean
latent
Number period of
showing sarcoma Number of mice resistant to sarcomas at week
local induction ___
Group Numbers reaction (weeks) 10 11 12 13 14 15 16 17 18 19 20 25 30 35 40
Thymus Total 12 3 14-6 12 12 9 8 7 6 3 3 2 1 1 1 1 1 1
grafted
(6 male) 1 14-0 6 6 4 3 3 3 0 0 0 0 0 0 0 0 0
(6 female) 2 15-3 6 6 5L 5 4 3L 3 3 2 1 1 1 1 1 IM
Controls Totl 12 9 15-5 12 12 12 11 8 6 5 4 3 2 1 1 - - -
(6 male) 5 15-0 6 6 6 5 3 2 2 1 1 1 0 0 0 0 0
(6 female) 4 16-0 6 6 6 6 5 4 3 3 2P 1 1 1H_ -
Castrated Total 26 15 18-1 26 24 22 19 18 16 12 12 11 8 6 4 1 0 0
(12 male) 9 17-0 12 11 10 9 8 8 6 6 5 3 2 1 0 0 0
(14 female) 6 19d1 14 13 12 10 10 8 6 6 6 5 4 3 1 0 0
L Developed leukaemia as well as sarcoma (2 animals).
P Developed skin papilloma as well as sarcoma.
H Developed haemangioma at injection site at 27 weeks, but no sarcoma.
M Developed mammary adenocarcinoma at injection site at 43 weeks, but no sarcoma.
It will be seen from Table I that more local reactions at the injection site
occurred in control animals than in thymus-grafted animals. This difference was
statistically significant (Chi-square = 8-167, df = 1, P < 0-01).
No delay in the rate of sarcoma induction was found in the thymus-grafted
group when compared with the control animals. However, breakdown of both
these groups into the two sexes did reveal some slight sex differences. While
male animals all responded within 20 weeks by developing sarcomas only, the
response of female mice was much more varied. Ofthymus-grafted females, two
developed early leukaemias in addition to their sarcomas, while one survived
sarcoma free for 43 weeks, eventually developing mammary adenocarcinoma at
the injection site. One of the control females developed a skin papilloma in
addition to its sarcoma, while another remained sarcoma free, developing haeman-
gioma at the injection site after 27 weeks.
The Fisher exact probability test (Siegel, 1956) was used to determine whether
males and females differed in the proportions bearing sarcomas at any particular
time. The difference was significant at 17 weeks (P _ 0.03238) with males being
more sensitive, but not significant at 16 weeks (P 0.09999) or at 18 weeks
(P = 0-15975).
In the two groups of castrated animals, every mouse developed a sarcoma at
the site ofMC injection and no tumours of any other kind were seen. There was
no significant difference in the mean latent period of induction, which was 17.3
weeks for castrated males and 19-1 weeks for castrated females (t- 0-667,
df = 24, P > 0-5).
There was some variation in growth rate of different sarcomas. When the
growth curves were drawn, a greater number that approached a straight line were
found in males than in females.JUNE MARCHANT
DISCUSSION
In the present experiment no delay in sarcoma induction occurred as a result
of thymus grafting. Miller (1962a, 1962b) has shown that grafting of an intact
thymus from a neonatal donor into a neonatally thymectomised syngeneic mouse
will prevent the wasting syndrome and restore full immunological competence.
Similar grafts contribute to the restoration of immunological function in adult
mice which have been thymectomised and irradiated (Leuchars et al., 1965).
Protection from the effects of neonatal thymectomy can also be attained by
implantation within the peritoneal cavity of a cell-tight Millipore diffusion chamber
containing a new-born thymus gland, indicating a hormonal effect (Levey et al.,
1963). There would seem no doubt, therefore, that a thymus graft can contribute
to the recovery of immunological function impaired by thymectomy. The present
experiments, however, have failed to lend support to Maisin's suggestion that
regular thymus grafts stimulate any recovery of immune response which may
have been depressed by injection of MC. It is possible that the number of
animals used were too small to detect any effect of thymus grafting. Maisin
(1963, 1964) used groups of 70 to 80 mice (equal numbers of both sexes), whereas
there were only 12 mice per group in the present pilot experiment.
Despite a failure to reveal any effect of thymus grafting on sarcoma induction,
it was possible to detect with the small numbers of animals used here a greater
variability of response to MC injection among female mice than among males or
castrated animals of either sex. From 16 to 18 weeks following injection of the
carcinogen, there was a higher incidence of sarcomas in males than in females.
This difference was statistically significant at 17 weeks. All the males and the
castrated animals responded by developing sarcomas only, while some intact
females remained resistant to sarcomas and others developed a variety of other
tumours in addition to their sarcomas.
The tissues responding to the carcinogenic action of MC in females appear to
be tissues on which female hormones are known to have a mitogenic effect
namely, the mammary gland (Cole, 1933), the epidermis (Bullough and van Oordt,
1950) and lymphoid tissues (Metcalf, 1962). This suggests that hormonal pro-
liferation in these tissues may be a contributory feature of their susceptibility to
the carcinogenic action of MC. The author has noted an earlier onset of skin
tumours in females than in males following skin painting of albino mice from a
closed colony with MC solution, while castration caused a delay in papilloma
appearance in both sexes (Marchant, 1959). However, Maisin (1963, 1964) did
not report any sex difference in skin tumour appearance in his experiments with
mice of the
" L strain
" painted with this carcinogen.
The present experiments indicate some resistance of female mice to sarcoma
induction by MC. Balner and Dersjant (1966) also obtained a lower incidence of
sarcomas in females than males following intradermal injection of 1.0 mg. MC in
C57BL and F1 (C57BL x CBA) mice. Female hormones may have a depressive
effect on the activity of dermal fibroblasts, for Hamer and Marchant (1957)
found that the collagen content of female mouse skin was considerably less than
that of males or of castrates of either sex. On the other hand, the apparent
resistance of some females to sarcoma induction by MC could have an immuno-
logical basis. Female mice are known to be more resistant to immunological
challenge than males (Old et al., 1962) and they may therefore be better able to
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resist the growth of antigenic tumour cells. Oestrogen is also known to stitnulate
phagocytosis by cells of the reticulo-endothelial system (Nicol et al., 1964) and
may thereby speed up an immune response in females. It would seem desirable
in experiments with MC to be aware of the possibility that sex differences in
tumour response may mask small effects due to differences in other experimental
conditions.
The significance ofthe localised swellings preceding the appearance of tumours
in some animals is obscure. They were also noted by Johnson (1968), who found
they were less frequent in thymectomised mice than controls and she suggested
that they may represent a reaction to early-arising, highly antigenic tumour cells.
Their occurrence requires further investigation.
SUIMMARY
F1 (C57BL x IF) mice of both sexes received thymus grafts once a fortnight
from syngeneic animals 6 to 10 days old and were given subcutaneous injections
of 1 mg. 3-methylcholanthrene (MC) in olive oil. Tumour induction was compared
with that in normal animals. No difference could be detected between thymus
grafted animals and controls. While all males responded with sarcomas only,
females showed some resistance to sarcoma induction and developed various other
neoplasms. When additional animals of both sexes were castrated and given MC
injections but no thymus grafts, they developed sarcomas only.
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